Schedule 13G ownership disclosure
INOTEK PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 45780V102
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,980,842
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-17-000049
- Form type
- SC 13G
- Filer
- ROCKET PHARMACEUTICALS, INC.
- CIK
- CIK 1281895
- Filed
- Feb 03, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership